Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (371)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
34
2024
2046
5.240
Why?
Machine Learning
7
2024
513
2.250
Why?
Stroke Volume
17
2025
571
2.000
Why?
Adrenergic beta-Antagonists
10
2025
221
1.600
Why?
Methadone
5
2023
99
1.540
Why?
Pregnancy Complications, Cardiovascular
5
2022
75
1.490
Why?
Buprenorphine
3
2023
176
1.370
Why?
Cardiomyopathies
5
2022
324
1.360
Why?
United States Food and Drug Administration
5
2024
200
1.240
Why?
Decision Support Systems, Clinical
6
2024
236
1.230
Why?
Cardiomyopathy, Dilated
9
2025
323
1.180
Why?
Pharmacogenetics
5
2024
165
1.160
Why?
Adverse Drug Reaction Reporting Systems
4
2024
77
1.130
Why?
Arrhythmias, Cardiac
6
2023
326
1.100
Why?
Electronic Health Records
7
2024
1087
1.020
Why?
Cytochrome P-450 CYP2C19
4
2024
25
1.000
Why?
Propanolamines
3
2019
32
0.930
Why?
Hospitalization
10
2024
2182
0.900
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
451
0.870
Why?
Workflow
1
2024
164
0.820
Why?
Telemedicine
4
2024
863
0.800
Why?
Torsades de Pointes
4
2016
20
0.740
Why?
Seasons
1
2024
541
0.740
Why?
Pulmonary Edema
1
2021
112
0.710
Why?
Humans
85
2025
136965
0.710
Why?
Coffee
1
2021
16
0.700
Why?
Stroke
2
2021
1124
0.680
Why?
Pharmacogenomic Testing
4
2022
60
0.670
Why?
Defibrillators, Implantable
2
2021
304
0.660
Why?
Platelet Aggregation Inhibitors
1
2024
465
0.650
Why?
Aged
31
2025
23803
0.630
Why?
Prosthesis Failure
1
2020
123
0.610
Why?
Prosthesis-Related Infections
1
2020
98
0.600
Why?
Mobile Applications
1
2021
178
0.600
Why?
Long QT Syndrome
3
2016
68
0.600
Why?
Device Removal
1
2020
135
0.600
Why?
Spironolactone
1
2019
34
0.590
Why?
Pacemaker, Artificial
1
2020
113
0.590
Why?
United States
21
2024
14945
0.580
Why?
Mineralocorticoid Receptor Antagonists
1
2019
55
0.580
Why?
Medical Records
2
2019
180
0.580
Why?
Coronary Disease
1
2021
371
0.580
Why?
Diabetes Mellitus
2
2024
1056
0.570
Why?
Biomedical Research
2
2024
700
0.560
Why?
Periodicals as Topic
1
2020
211
0.560
Why?
Mortality
3
2019
356
0.550
Why?
Retrospective Studies
21
2024
15536
0.550
Why?
Risk Assessment
8
2024
3446
0.530
Why?
Hypertension, Pregnancy-Induced
1
2018
67
0.520
Why?
Female
48
2025
73002
0.520
Why?
Receptors, Transforming Growth Factor beta
1
2017
58
0.520
Why?
Hospital Records
1
2016
10
0.510
Why?
Atrial Fibrillation
3
2019
377
0.510
Why?
Analgesics, Opioid
2
2023
1039
0.510
Why?
Ventricular Function, Left
5
2025
500
0.510
Why?
Proteoglycans
1
2017
107
0.500
Why?
Hospital Mortality
6
2024
895
0.500
Why?
Artificial Intelligence
1
2019
291
0.480
Why?
Disease Management
1
2020
615
0.480
Why?
Survival
1
2015
38
0.470
Why?
Tetrazoles
1
2015
42
0.470
Why?
Middle Aged
29
2025
33226
0.470
Why?
Male
40
2025
67386
0.460
Why?
Biphenyl Compounds
1
2015
63
0.460
Why?
Muscle Proteins
2
2025
229
0.460
Why?
Myocardial Infarction
3
2018
1046
0.450
Why?
Research Design
1
2020
1114
0.430
Why?
Ventricular Remodeling
3
2025
255
0.420
Why?
Loperamide
2
2023
11
0.420
Why?
Registries
2
2020
2048
0.410
Why?
Myocardium
3
2017
895
0.410
Why?
Tachycardia, Ventricular
1
2015
169
0.400
Why?
Adult
28
2024
37715
0.400
Why?
Polymorphism, Single Nucleotide
4
2017
2142
0.400
Why?
Precision Medicine
6
2024
415
0.400
Why?
Diet
1
2021
1279
0.390
Why?
Legislation, Medical
1
2012
10
0.390
Why?
Amiodarone
1
2012
26
0.380
Why?
Peripartum Period
4
2022
19
0.380
Why?
Phenotype
5
2025
3148
0.380
Why?
Patient Readmission
1
2018
699
0.370
Why?
Quality Improvement
2
2020
1178
0.370
Why?
Anti-Arrhythmia Agents
1
2012
109
0.370
Why?
Heart Arrest
4
2019
336
0.350
Why?
Catheter Ablation
1
2015
330
0.350
Why?
Sex Factors
4
2024
2060
0.350
Why?
Pyrazines
2
2008
85
0.350
Why?
Treatment Outcome
10
2025
10664
0.350
Why?
Triazoles
2
2008
150
0.340
Why?
Cardiovascular Diseases
5
2024
2115
0.330
Why?
Transfusion Reaction
1
2011
60
0.330
Why?
Forecasting
2
2024
386
0.330
Why?
Postoperative Complications
2
2020
2622
0.330
Why?
Heart-Assist Devices
1
2016
545
0.330
Why?
Echocardiography
3
2024
639
0.330
Why?
Insurance, Health
1
2012
287
0.320
Why?
Patient Transfer
1
2012
174
0.320
Why?
Patient Discharge
2
2021
901
0.320
Why?
Databases, Factual
5
2020
1367
0.310
Why?
Anemia
1
2011
171
0.310
Why?
Thiazolidinediones
1
2010
137
0.300
Why?
Risk Factors
9
2024
10363
0.300
Why?
Aged, 80 and over
7
2024
7559
0.300
Why?
Genotype
3
2024
1872
0.300
Why?
Marketing
1
2008
33
0.300
Why?
Rhabdomyolysis
1
2008
21
0.290
Why?
Renal Insufficiency
1
2011
160
0.290
Why?
Simvastatin
1
2008
60
0.290
Why?
Heart Ventricles
4
2017
738
0.290
Why?
Receptors, Adrenergic, beta-1
4
2019
23
0.290
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
46
0.280
Why?
Heart Rate
3
2025
794
0.280
Why?
Length of Stay
4
2024
1192
0.280
Why?
Electrocardiography
4
2019
607
0.270
Why?
Cytochrome P-450 CYP2D6
3
2022
30
0.270
Why?
Drug Industry
1
2008
109
0.270
Why?
Kaplan-Meier Estimate
3
2016
868
0.270
Why?
Proportional Hazards Models
4
2021
1251
0.270
Why?
Practice Patterns, Physicians'
3
2020
1295
0.260
Why?
Pharmacovigilance
2
2024
23
0.260
Why?
Elective Surgical Procedures
2
2020
180
0.250
Why?
Follow-Up Studies
6
2024
5048
0.250
Why?
Incidence
5
2024
2793
0.250
Why?
Biological Specimen Banks
3
2024
100
0.250
Why?
Emergency Service, Hospital
2
2020
2080
0.240
Why?
Patient Reported Outcome Measures
2
2020
399
0.240
Why?
Gene Expression Regulation
1
2015
2574
0.240
Why?
Cause of Death
2
2019
428
0.230
Why?
Glucose
1
2010
1029
0.220
Why?
New York
1
2024
123
0.220
Why?
Diabetic Cardiomyopathies
1
2024
35
0.220
Why?
Pandemics
3
2022
1630
0.220
Why?
Young Adult
9
2022
13218
0.210
Why?
Pregnancy
6
2022
6736
0.210
Why?
Acute Kidney Injury
2
2008
802
0.210
Why?
Diphenoxylate
1
2023
5
0.210
Why?
Randomized Controlled Trials as Topic
3
2021
1460
0.210
Why?
Adolescent
10
2020
21471
0.200
Why?
Nonprescription Drugs
1
2023
63
0.200
Why?
Monitoring, Physiologic
1
2024
266
0.190
Why?
Heart Defects, Congenital
2
2020
828
0.190
Why?
Prognosis
5
2020
3931
0.190
Why?
Medicare
2
2020
785
0.190
Why?
Naltrexone
1
2023
97
0.190
Why?
Insulin Resistance
1
2010
1226
0.180
Why?
Time Factors
3
2020
6786
0.180
Why?
Speech
1
2021
70
0.170
Why?
Red Meat
1
2021
19
0.170
Why?
Smartphone
1
2021
89
0.170
Why?
Drug Dosage Calculations
1
2020
22
0.170
Why?
Losartan
1
2020
14
0.170
Why?
Lisinopril
1
2020
13
0.170
Why?
Data Interpretation, Statistical
2
2020
357
0.170
Why?
Cardiac Resynchronization Therapy
1
2021
40
0.170
Why?
Protective Factors
1
2021
94
0.170
Why?
Hypoglycemic Agents
1
2010
1298
0.170
Why?
Angioedema
1
2020
16
0.170
Why?
Actigraphy
1
2021
115
0.170
Why?
Hypertension
2
2020
1299
0.170
Why?
Wearable Electronic Devices
1
2021
53
0.170
Why?
American Heart Association
2
2019
301
0.170
Why?
Turner Syndrome
1
2021
54
0.170
Why?
Referral and Consultation
2
2017
779
0.160
Why?
Biological Products
1
2023
217
0.160
Why?
Data Accuracy
1
2020
65
0.160
Why?
Milk
1
2021
124
0.160
Why?
California
2
2012
437
0.160
Why?
Indans
1
2020
12
0.160
Why?
Oxadiazoles
1
2020
32
0.160
Why?
Bionics
1
2019
12
0.160
Why?
Editorial Policies
1
2020
52
0.160
Why?
Medical Futility
1
2019
24
0.160
Why?
Medical Informatics
1
2020
100
0.160
Why?
Software
2
2015
662
0.160
Why?
Fingolimod Hydrochloride
1
2020
40
0.160
Why?
Medical Record Linkage
1
2020
66
0.160
Why?
Information Storage and Retrieval
1
2020
118
0.150
Why?
Prescription Drugs
1
2020
114
0.150
Why?
Drug Overdose
1
2023
354
0.150
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
76
0.150
Why?
Drug Prescriptions
1
2021
258
0.150
Why?
Sitagliptin Phosphate
2
2008
32
0.150
Why?
Medical Order Entry Systems
1
2019
43
0.150
Why?
Child Health Services
1
2020
188
0.150
Why?
Dose-Response Relationship, Drug
4
2020
2015
0.150
Why?
Cohort Studies
3
2021
5688
0.140
Why?
Social Determinants of Health
1
2022
261
0.140
Why?
Tobacco Use
1
2019
63
0.140
Why?
Computer Graphics
2
2015
41
0.140
Why?
Cluster Analysis
1
2019
513
0.140
Why?
Gene Regulatory Networks
2
2023
309
0.140
Why?
Receptors, Histamine H2
1
2017
6
0.140
Why?
Florida
1
2018
107
0.140
Why?
Advisory Committees
1
2019
217
0.140
Why?
Porins
1
1997
17
0.130
Why?
Neisseria gonorrhoeae
1
1997
28
0.130
Why?
Prospective Studies
4
2021
7512
0.130
Why?
Dyslipidemias
1
2019
178
0.130
Why?
Academic Medical Centers
1
2020
504
0.130
Why?
Nursing Assessment
1
2017
57
0.130
Why?
Heart Diseases
1
2020
325
0.130
Why?
Antihypertensive Agents
1
2020
495
0.130
Why?
Pressure Ulcer
1
2017
46
0.130
Why?
Patient Participation
1
2020
424
0.130
Why?
Cardiology
1
2019
271
0.130
Why?
Population Surveillance
1
2020
487
0.130
Why?
Hospitals, Teaching
1
2017
113
0.130
Why?
Tilidine
1
2016
2
0.130
Why?
Double-Blind Method
3
2025
1904
0.120
Why?
Consensus
1
2019
675
0.120
Why?
Genetic Markers
1
2017
346
0.120
Why?
Oxycodone
1
2016
48
0.120
Why?
Databases, Genetic
1
2017
239
0.120
Why?
Rheumatic Heart Disease
1
2015
7
0.120
Why?
Sex Distribution
1
2016
373
0.120
Why?
Rheumatic Fever
1
2015
10
0.120
Why?
Cholesterol Ester Transfer Proteins
1
2015
18
0.120
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.120
Why?
Hospitals, Low-Volume
1
2015
23
0.110
Why?
Angiotensin II
1
2015
96
0.110
Why?
Naloxone
1
2016
121
0.110
Why?
Gene Expression Profiling
3
2017
1747
0.110
Why?
Computational Biology
2
2017
647
0.110
Why?
Hospitals, High-Volume
1
2015
43
0.110
Why?
Immunosuppressive Agents
1
2020
861
0.110
Why?
Marijuana Use
1
2018
205
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
756
0.110
Why?
Percutaneous Coronary Intervention
1
2020
482
0.110
Why?
United Kingdom
1
2015
315
0.110
Why?
Mothers
1
2020
758
0.110
Why?
Biomarkers
2
2024
4095
0.110
Why?
International Classification of Diseases
1
2015
136
0.110
Why?
Age Factors
2
2019
3258
0.110
Why?
Comorbidity
1
2019
1626
0.110
Why?
Chronic Disease
2
2020
1774
0.100
Why?
Narcotic Antagonists
1
2015
181
0.100
Why?
Gene Expression
2
2017
1480
0.100
Why?
Ventricular Dysfunction, Left
2
2020
362
0.100
Why?
Down-Regulation
1
2015
633
0.100
Why?
MicroRNAs
2
2017
677
0.100
Why?
Cholesterol
1
2015
411
0.100
Why?
Coronary Artery Disease
1
2019
698
0.100
Why?
Myocytes, Cardiac
1
2017
505
0.100
Why?
Federal Government
1
2012
27
0.100
Why?
RNA, Messenger
2
2017
2788
0.090
Why?
Drug Resistance
1
2012
145
0.090
Why?
Area Under Curve
1
2012
303
0.090
Why?
Genetic Predisposition to Disease
2
2017
2371
0.090
Why?
Predictive Value of Tests
1
2017
1999
0.090
Why?
Patient Safety
1
2015
313
0.090
Why?
Colorado
4
2024
4542
0.090
Why?
Opiate Substitution Treatment
1
2013
155
0.090
Why?
Gastrointestinal Hemorrhage
1
2012
133
0.090
Why?
Anti-Retroviral Agents
1
2013
240
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
1027
0.090
Why?
Pregnancy Outcome
1
2013
416
0.090
Why?
Survival Rate
1
2015
1882
0.080
Why?
Bayes Theorem
1
2012
410
0.080
Why?
Managed Care Programs
2
2022
141
0.080
Why?
Genome-Wide Association Study
1
2017
1395
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
228
0.080
Why?
Delivery of Health Care
1
2017
957
0.080
Why?
Emergency Medical Services
1
2015
556
0.080
Why?
Multivariate Analysis
1
2012
1484
0.070
Why?
Severity of Illness Index
1
2017
2809
0.070
Why?
Pharmacogenomic Variants
2
2019
33
0.070
Why?
Drug Approval
1
2008
86
0.070
Why?
Primary Health Care
1
2019
1775
0.070
Why?
Vasodilator Agents
1
2010
319
0.070
Why?
Logistic Models
1
2012
2066
0.070
Why?
Kidney Function Tests
1
2007
157
0.070
Why?
Animals
3
2023
36882
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
247
0.060
Why?
Zimbabwe
2
2017
58
0.060
Why?
Drug Therapy, Combination
1
2008
1022
0.060
Why?
Opioid-Related Disorders
1
2013
532
0.060
Why?
Models, Biological
1
2012
1780
0.060
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
35
0.060
Why?
Case-Control Studies
1
2012
3556
0.060
Why?
Psychological Tests
1
2005
135
0.050
Why?
Osteoporosis, Postmenopausal
1
2004
42
0.050
Why?
Potassium Channels
1
2025
147
0.050
Why?
Depression
2
2022
1454
0.050
Why?
Mandible
1
2004
68
0.050
Why?
Cross-Sectional Studies
3
2022
5530
0.050
Why?
Receptors, Adrenergic
1
2023
21
0.050
Why?
Drug Administration Schedule
2
2020
749
0.050
Why?
Cardiovascular Agents
1
2025
152
0.050
Why?
Algorithms
3
2020
1700
0.050
Why?
Carcinoembryonic Antigen
1
2002
36
0.050
Why?
Antigens, Differentiation
1
2002
81
0.050
Why?
Child
5
2020
21760
0.050
Why?
Antigens, Bacterial
1
2002
127
0.040
Why?
Electronic Prescribing
1
2021
3
0.040
Why?
Cell Adhesion Molecules
1
2002
176
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
12
0.040
Why?
Health Services Misuse
1
2020
32
0.040
Why?
Insurance Claim Reporting
1
2020
24
0.040
Why?
Antidepressive Agents
1
2022
242
0.040
Why?
Lymphocyte Count
1
2020
147
0.040
Why?
Morbidity
1
2020
319
0.040
Why?
Antigens, Neoplasm
1
2002
316
0.040
Why?
Membrane Glycoproteins
1
2002
496
0.040
Why?
Metoprolol
1
2019
21
0.040
Why?
Antineoplastic Agents
1
2010
2111
0.040
Why?
Grounded Theory
1
2019
36
0.040
Why?
Antigens, CD
1
2002
527
0.040
Why?
Aftercare
1
2020
208
0.040
Why?
Bias
1
2020
222
0.040
Why?
Genomics
1
2024
804
0.040
Why?
HIV Infections
1
2013
2898
0.040
Why?
Mice, Transgenic
1
2023
2156
0.040
Why?
Coronary Angiography
1
2020
314
0.030
Why?
Delivery of Health Care, Integrated
1
2020
281
0.030
Why?
Amino Acid Sequence
2
2002
2139
0.030
Why?
Static Electricity
1
1997
117
0.030
Why?
Exercise Test
1
2020
617
0.030
Why?
Molecular Sequence Data
2
2002
2900
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
79
0.030
Why?
Inpatients
1
2021
496
0.030
Why?
Focus Groups
1
2019
535
0.030
Why?
Frail Elderly
1
2017
130
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
347
0.030
Why?
Socioeconomic Factors
1
2020
1310
0.030
Why?
Puerperal Disorders
1
2016
31
0.030
Why?
Metabolic Networks and Pathways
1
2017
182
0.030
Why?
World Health Organization
1
2016
124
0.030
Why?
Physician-Patient Relations
1
2020
577
0.030
Why?
Neoplasms
1
2010
2698
0.030
Why?
Drug Combinations
1
2016
341
0.030
Why?
Decision Trees
1
2015
88
0.030
Why?
Data Mining
1
2015
116
0.030
Why?
Cell Membrane
1
1997
710
0.030
Why?
Blood Pressure
1
2020
1786
0.030
Why?
Biopsy
1
2017
1083
0.030
Why?
Pediatrics
1
2020
1061
0.020
Why?
Reproducibility of Results
1
2020
3266
0.020
Why?
Models, Genetic
1
2015
586
0.020
Why?
Infant
2
2015
9392
0.020
Why?
Liver
1
2020
1867
0.020
Why?
Mass Screening
2
2013
1295
0.020
Why?
Anthracyclines
1
2010
42
0.020
Why?
Child, Preschool
2
2015
10952
0.020
Why?
Trastuzumab
1
2010
96
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
96
0.020
Why?
Signal Transduction
1
2023
5047
0.020
Why?
Clinical Trials as Topic
1
2015
1019
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
195
0.020
Why?
Program Evaluation
1
2013
907
0.020
Why?
Apoptosis
1
2017
2542
0.020
Why?
Injections, Intravenous
1
2007
197
0.020
Why?
Natriuretic Peptide, Brain
1
2007
97
0.020
Why?
Infusions, Intravenous
1
2007
392
0.020
Why?
Ultrasonography
1
2010
761
0.020
Why?
Mice
1
2023
17705
0.020
Why?
Creatinine
1
2007
486
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
798
0.010
Why?
Hospitals, University
1
2005
178
0.010
Why?
Dentists
1
2004
21
0.010
Why?
Femur Neck
1
2004
61
0.010
Why?
Bone Diseases, Metabolic
1
2004
63
0.010
Why?
Antibodies, Monoclonal
1
2010
1412
0.010
Why?
Absorptiometry, Photon
1
2004
264
0.010
Why?
Nurses
1
2005
184
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
25
0.010
Why?
Analysis of Variance
1
2004
1301
0.010
Why?
HeLa Cells
1
2002
632
0.010
Why?
Bone Density
1
2004
488
0.010
Why?
Binding Sites
1
2002
1310
0.010
Why?
Clinical Competence
1
2005
1114
0.010
Why?
Physicians
1
2005
921
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)